TED Ted Baker Plc

    RNS Number : 9033A
  Tepnel Life Sciences PLC
  07 August 2008
   


    Tepnel Life Sciences plc ("Tepnel" or the "Company")

    Director holdings


    Manchester, UK - 7 August 2008 Tepnel Life Sciences PLC (AIM: TED), the UK-
based international Molecular Diagnostics and Research Products & Services group, was
    informed on 6 August 2008 that Alec Craig, Non-Executive Chairman, purchased 250,000 ordinary
    shares in the Company on 6 August 2008 at 10.7p each.  

    Mr Craig is now interested in 2,000,000 ordinary shares representing approximately 0.87 per
    cent. of the ordinary issued share capital of the Company.



    For Further Information:

    Tepnel Life Sciences plc
    Ben Matzilevich, CEO
    Michael Slater, Group Finance Director
    Carol Smith, Group Marketing Communications Manager
    0161 946 2200

    Capital MS&L
    Mary Clark or Joey Whineray
    Tel: +44 20 7307 5330

    Seymour Pierce Limited
Mark Percy
    Tel: +44 20 7107 8000





    Notes to Editors

    About Tepnel Life Sciences plc
    Tepnel Life Sciences (AIM:TED) is a UK-based international life sciences products and services group with two main divisions, Molecular
Diagnostics and Research Products & Services. The Company has laboratories, manufacturing and operations in the USA, UK and France over 200
employees.  Tepnel provides test kits, reagents and services to two highly synergistic markets, these being Molecular Diagnostics and
Biomedical Research.  The Company's strategy has been to identify high growth niche opportunities within these multi-billion pound markets. 
Tepnel focuses on these niche opportunities with internally developed products, patents, expertise and know-how as well as strategic
acquisitions, to develop a leadership position within these defined market segments.

This information is provided by RNS
The company news service from the London Stock Exchange
 
  END 
 
RDSBUGDIGGGGGIR

Ted Baker (LSE:TED)
Historical Stock Chart
From Jun 2024 to Jul 2024

Ted Baker (LSE:TED)
Historical Stock Chart
From Jul 2023 to Jul 2024